BACKGROUND: Mycobacterium africanum, a member of the M. tuberculosis complex that is infrequently found outside of western Africa, is the cause of up to half of the tuberculosis cases there. METHODS: We genotyped mycobacterial isolates obtained from a study of patients with tuberculosis and their household contacts and compared T cell responses and tuberculin skin test results by infecting genotype. RESULTS: The T cell response to early secreted antigenic target, 6 kDa (ESAT-6), was attenuated in patients with tuberculosis (odds ratio [OR], 0.41 [95% confidence interval {CI}, 0.19-0.89]; P = .024) and household contacts (OR, 0.56 [95% CI, 0.38-0.83]; P = .004) infected with M. africanum, compared with the response in those infected with M. tuberculosis. In these same groups, responses to culture filtrate protein, 10 kDa (CFP-10), were nonsignificantly attenuated (P = .22 and P = .16, respectively), as were tuberculin skin test results (P = .30 and P = .46, respectively). Sequencing of region of difference 1 of M. africanum revealed that Rv3879c is a pseudogene in M. africanum; however, this finding does not provide an obvious mechanism for the attenuated ESAT-6 response. CONCLUSIONS: This is the first evidence, to our knowledge, that strain differences affect interferon- gamma -based T cell responses. Our findings highlight the need to test new diagnostic candidates against different strains of mycobacteria. Integrating additional immunologic and genomic comparisons of M. tuberculosis and M. africanum into further studies may provide fundamental insights into the interactions between humans and mycobacteria.
BACKGROUND: Mycobacterium africanum, a member of the M. tuberculosis complex that is infrequently found outside of western Africa, is the cause of up to half of the tuberculosis cases there. METHODS: We genotyped mycobacterial isolates obtained from a study of patients with tuberculosis and their household contacts and compared T cell responses and tuberculin skin test results by infecting genotype. RESULTS: The T cell response to early secreted antigenic target, 6 kDa (ESAT-6), was attenuated in patients with tuberculosis (odds ratio [OR], 0.41 [95% confidence interval {CI}, 0.19-0.89]; P = .024) and household contacts (OR, 0.56 [95% CI, 0.38-0.83]; P = .004) infected with M. africanum, compared with the response in those infected with M. tuberculosis. In these same groups, responses to culture filtrate protein, 10 kDa (CFP-10), were nonsignificantly attenuated (P = .22 and P = .16, respectively), as were tuberculin skin test results (P = .30 and P = .46, respectively). Sequencing of region of difference 1 of M. africanum revealed that Rv3879c is a pseudogene in M. africanum; however, this finding does not provide an obvious mechanism for the attenuated ESAT-6 response. CONCLUSIONS: This is the first evidence, to our knowledge, that strain differences affect interferon- gamma -based T cell responses. Our findings highlight the need to test new diagnostic candidates against different strains of mycobacteria. Integrating additional immunologic and genomic comparisons of M. tuberculosis and M. africanum into further studies may provide fundamental insights into the interactions between humans and mycobacteria.
Authors: D I Ling; M Pai; V Davids; L Brunet; L Lenders; R Meldau; G Calligaro; B Allwood; R van Zyl-Smit; J Peter; E Bateman; R Dawson; K Dheda Journal: Eur Respir J Date: 2011-02-24 Impact factor: 16.671
Authors: Jayne S Sutherland; Bouke C de Jong; David J Jeffries; Ifedayo M Adetifa; Martin O C Ota Journal: PLoS One Date: 2010-08-24 Impact factor: 3.240
Authors: Sidra E Gonçalves Vasconcellos; Richard C Huard; Stefan Niemann; Kristin Kremer; Adalberto R Santos; Philip N Suffys; John L Ho Journal: BMC Infect Dis Date: 2010-03-29 Impact factor: 3.090
Authors: Bouke C de Jong; Philip C Hill; Alex Aiken; Timothy Awine; Martin Antonio; Ifedayo M Adetifa; Dolly J Jackson-Sillah; Annette Fox; Kathryn Deriemer; Sebastien Gagneux; Martien W Borgdorff; Keith P W J McAdam; Tumani Corrah; Peter M Small; Richard A Adegbola Journal: J Infect Dis Date: 2008-10-01 Impact factor: 5.226
Authors: Manzour Hernando Hazbón; Alifiya S Motiwala; Magali Cavatore; Michael Brimacombe; Thomas S Whittam; David Alland Journal: Antimicrob Agents Chemother Date: 2008-06-30 Impact factor: 5.191
Authors: Bouke C de Jong; Abdulrahman Hammond; Jacob K Otu; Martin Antonio; Richard A Adegbola; Martin O Ota Journal: BMC Infect Dis Date: 2010-01-19 Impact factor: 3.090